At a glance
ClinicalIndex Comparison RecordN/ACompleted· 101 enrolled
Drug / intervention
No intervention planned.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Pancreatic Triglyceride Content in Beta-cell Function
University of Texas Southwestern Medical Center·observational·Posted Jan 28, 2008·Updated Dec 26, 2017
In Brief
An observational study evaluating No intervention planned. for Obesity and Type 2 Diabetes. Completed, enrolled 101 participants across 1 site.
Detailed Summary
The study evaluates if fat accumulates in the pancreas in individuals at risk of developing obesity-related diabetes. It also evaluates if the amount of fat in the pancreas can predict the residual functional capacity of the pancreas (insulin secretion).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Type 2 Diabetes
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedJan 2008
Primary CompletionAug 2012
TodayJul 2026
First PostedJan 28, 2008
Enrollment StartSep 1, 2007
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 18.4 years ago
Interventions
No intervention planned.other
This is a cross-sectional observational study, no intervention is planned.